Tilray Canada Ltd., a subsidiary of Tilray Inc. (NASDAQ: TLRY), a global pioneer in the production, research, and distribution of medical cannabis, announced today that it entered into a global framework agreement to collaborate with Sandoz AG, a global leader in generic pharmaceuticals and biosimilars and a part of Novartis group, to increase availability of high quality medical cannabis products across the world.
Articles
TerrAscend Wins New Jersey Medical Cannabis License
Receives Permit to apply for cannabis cultivation, processing and retail operations in populous Northern New Jersey region
New York Governor Announces Push To Legalize Marijuana, But There’s A Catch
New York state is going to legalize marijuana in 2019, but there’s a catch.
Tilray® Signs Letter of Intent for Hemp-Derived CBD from the U.S. and Canada
Tilray, Inc. (NASDAQ:TLRY), a global leader in cannabis research and production, today announced the terms of a binding letter of intent (“LOI”) to purchase hemp-derived CBD isolate from LiveWell Canada Inc. (CSE:LVWL), which will be sourced from the United States and Canada and utilized for distribution of Tilray-owned wellness and medical products across North America.
Namaste Enters Agreement with Pineapple Express
Namaste Technologies Inc.(TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) is pleased to announce that the Company has entered into a share purchase agreement to acquire common shares in Pineapple Express Delivery Inc. and an affiliated entity, representing an additional 34% equity in exchange for such number of common shares of Namaste having an aggregate value of approximately $3.06 Million. Upon completion of the Transaction, Namaste will own 49% of the outstanding common shares of Pineapple Express.
Organigram reports impressive growth for 2018 in advance of adult recreational sales results
Results to August 31, 2018 showcase a Canadian leader in low-cost cultivation while growing high-quality indoor product
TerrAscend Announces Agreement for US$75 Million Credit Facility
The credit facility is intended to give TerrAscend access to non-dilutive capital for acquisitions in the United States, as well as for general corporate and working capital purposes.
Aurora Cannabis Expands Retail Exposure Through Strategic Investment in High Tide
Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) (Frankfurt: 21P; WKN: A1C4WM) announced today that it has entered into an agreement to invest $10 million by way of brokered private placement in High Tide Inc. , a privately held, Alberta-based, retail-focused cannabis and lifestyle accessories company.
Canopy Growth announces multi-year extraction agreement with Valens GroWorks
Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) announces today that it has entered into a multi-year extraction agreement with Valens GroWorks Corp. (CSE: VGW) (OTC-PINK: MYMSF), a licensed, vertically integrated provider of cannabis products and services focused on various proprietary extraction methodologies, distillation, cannabinoid isolation and purification.
Aphria Signs Letter of Intent for Exclusive Supply Agreement with Insumos Medicos, S.A. to Supply Medical Cannabis in Paraguay
Aphria Inc. (TSX: APHA andNYSE: APHA) today announced that it has signed a Letter of Intent with Insumos Medicos S.A., a Paraguayan pharmaceutical manufacturing, import and distribution company, to enter into an exclusive supply and distribution agreement to provide medical cannabis in Paraguay.
These Marijuana Stocks Are Racing Higher When Everything Else Is Down
There’s a small group of marijuana-related stocks which have side-stepped the entire downturn.
Choom (CSE: CHOO) (OTCQB: CHOOF) Strengthens Ontario Retail Leadership
Choom is fast becoming a player to watch in the Canadian National Cannabis Retail space.
The Alkaline Water Company (NASDAQ | TSXV: WTER) Hits Record Sales and Starts Trading on NASDAQ
The Alkaline Water Company Inc. (NASDAQ and TSXV: WTER) begins trading on the NASDAQ today and celebrates by reporting their highest monthly sales in company history, exceeding $3.1 Million in November.
Liberty Health Sciences Reports $3.2 Million Florida Medical Cannabis Revenue in Q3
Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF), a provider of high quality cannabis, announced today that they experienced a significant increase in sales revenue in the quarter ended November 30, 2018 compared to the same period in the prior year.
